Development and In Vitro Evaluation of Controlled Release Viagra<sup>®</sup> Containing Poloxamer-188 Using Gastroplus<sup>™</sup> PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Sildenafil is the active substance in Viagra<sup>®</sup> tablets, which is approved by the FDA to treat sexual dysfunction in men. Poor solubility and short half-life, however, can limit the span of its effectiveness. Therefore, this study focused on an oral controlled release matrix sys...
Main Authors: | Mosab Arafat, Muhammad Sarfraz, Salahdein AbuRuz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/5/479 |
Similar Items
-
In Vitro and In Vivo Evaluation of Oral Controlled Release Formulation of BCS Class I Drug Using Polymer Matrix System
by: Mosab Arafat, et al.
Published: (2021-09-01) -
Tissue Distribution Study of Poloxamer188 in Rats by Ultra-High-Performance Liquid Chromatography Quadrupole Time of Flight/Mass Spectrometry with MS<sup>ALL</sup>-Based Approach
by: Yixuan Feng, et al.
Published: (2021-09-01) -
Effects of poloxamer 188 on traumatic brain injury
by: Renqing Wu, et al.
Published: (2024-07-01) -
The Effect of Glucose and Poloxamer 188 on Red-Blood-Cell Aggregation
by: Alicja Szołna-Chodór, et al.
Published: (2021-12-01) -
Preparation of Methotrexate loaded PLGA nanoparticles coated with PVA and Poloxamer188
by: Fatemeh Madani, et al.
Published: (2018-01-01)